XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 2,386,608 $ 989,888
Accounts receivable 1,129 1,916
Inventory 71,310 23,771
Prepaid expenses 25,046 2,778
Deposits 7,590 7,590
Total Current Assets 2,491,683 1,025,943
Equipment (net of $60,774 and $51,485 depreciation) 10,232 19,531
Patents (net of $58,918 amortization and $556,120 impairment) 0 0
TOTAL ASSETS 2,501,915 1,045,474
Current Liabilities:    
Notes payable 330,000 820,454
Notes payable - related party 0 143,661
Accounts payable & accrued expenses 56,687 62,870
Interest payable 84,945 24,320
Total Current Liabilities 471,632 1,051,305
Long-term portion of notes payable 3,204,215 949,006
TOTAL LIABILITIES 3,675,847 2,000,311
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY (DEFICIT)    
Common Stock, $0.001 par value per share; Authorized 3,000,000,000 Shares; Issued and outstanding 510,093,265 and 346,419,296 at September 30, 2021 and December 31, 2020 respectively 510,092 346,418
Capital paid in excess of par value 31,555,741 18,820,343
Accumulated comprehensive income (17,475) (2,871)
Accumulated (Deficit) (33,322,290) (20,218,727)
TOTAL SHAREHOLDERS' EQUITY (DEFICIT) (1,173,932) (954,837)
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) 2,501,915 1,045,474
Series B Preferred Stock [Member]    
SHAREHOLDERS' EQUITY (DEFICIT)    
Preferred stock value $ 100,000 $ 100,000